"Histone Deacetylase Inhibitors/therapeutic use"[MeSH Terms] - Search Results

Year	Number of Results
2005	1
2006	1
2007	2
2008	3
2009	67
2010	238
2011	265
2012	266
2013	271
2014	284
2015	295
2016	266
2017	260
2018	249
2019	196
2020	210
2021	218
2022	167
2023	146
2024	52

1

Recent developments of HDAC inhibitors: Emerging indications and novel molecules.

Bondarev AD, Attwood MM, Jonsson J, Chubarev VN, Tarasov VV, Schiöth HB. Bondarev AD, et al. Br J Clin Pharmacol. 2021 Dec;87(12):4577-4597. doi: 10.1111/bcp.14889. Epub 2021 May 27. Br J Clin Pharmacol. 2021. PMID: 33971031 Free article. Review.

2

Advances and Challenges of HDAC Inhibitors in Cancer Therapeutics.

McClure JJ, Li X, Chou CJ. McClure JJ, et al. Adv Cancer Res. 2018;138:183-211. doi: 10.1016/bs.acr.2018.02.006. Epub 2018 Mar 1. Adv Cancer Res. 2018. PMID: 29551127 Review.

3

SIRT1: A Potential Therapeutic Target in Autoimmune Diseases.

Shen P, Deng X, Chen Z, Ba X, Qin K, Huang Y, Huang Y, Li T, Yan J, Tu S. Shen P, et al. Front Immunol. 2021 Nov 23;12:779177. doi: 10.3389/fimmu.2021.779177. eCollection 2021. Front Immunol. 2021. PMID: 34887866 Free PMC article. Review.

4

Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer.

Damaskos C, Garmpis N, Valsami S, Kontos M, Spartalis E, Kalampokas T, Kalampokas E, Athanasiou A, Moris D, Daskalopoulou A, Davakis S, Tsourouflis G, Kontzoglou K, Perrea D, Nikiteas N, Dimitroulis D. Damaskos C, et al. Anticancer Res. 2017 Jan;37(1):35-46. doi: 10.21873/anticanres.11286. Anticancer Res. 2017. PMID: 28011471 Review.

5

Histone deacetylase inhibitors in hepatocellular carcinoma: A therapeutic perspective.

Tsilimigras DI, Ntanasis-Stathopoulos I, Moris D, Spartalis E, Pawlik TM. Tsilimigras DI, et al. Surg Oncol. 2018 Dec;27(4):611-618. doi: 10.1016/j.suronc.2018.07.015. Epub 2018 Jul 30. Surg Oncol. 2018. PMID: 30449480 Review.

6

The potential use of histone deacetylase inhibitors in the treatment of depression.

Fuchikami M, Yamamoto S, Morinobu S, Okada S, Yamawaki Y, Yamawaki S. Fuchikami M, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jan 4;64:320-4. doi: 10.1016/j.pnpbp.2015.03.010. Epub 2015 Mar 25. Prog Neuropsychopharmacol Biol Psychiatry. 2016. PMID: 25818247 Review.

7

Histone Deacetylase Inhibitors: A Novel Therapeutic Weapon Against Medullary Thyroid Cancer?

Damaskos C, Garmpis N, Valsami S, Spartalis E, Antoniou EA, Tomos P, Karamaroudis S, Zoumpou T, Pergialiotis V, Stergios K, Michaelides C, Kontzoglou K, Perrea D, Nikiteas N, Dimitroulis D. Damaskos C, et al. Anticancer Res. 2016 Oct;36(10):5019-5024. doi: 10.21873/anticanres.11070. Anticancer Res. 2016. PMID: 27798860 Review.

8

Therapeutic potential of histone deacetylase inhibitors in pancreatic cancer.

Feng W, Zhang B, Cai D, Zou X. Feng W, et al. Cancer Lett. 2014 Jun 1;347(2):183-90. doi: 10.1016/j.canlet.2014.02.012. Epub 2014 Feb 15. Cancer Lett. 2014. PMID: 24534202 Review.

9

Histone Deacetylase Inhibitors in Cancer Therapy.

Sun Y, Sun Y, Yue S, Wang Y, Lu F. Sun Y, et al. Curr Top Med Chem. 2018;18(28):2420-2428. doi: 10.2174/1568026619666181210152115. Curr Top Med Chem. 2018. PMID: 30526462 Review.

10

Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy.

Biswas S, Rao CM. Biswas S, et al. Eur J Pharmacol. 2018 Oct 15;837:8-24. doi: 10.1016/j.ejphar.2018.08.021. Epub 2018 Aug 18. Eur J Pharmacol. 2018. PMID: 30125562 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

2,967 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

2,967 results

Results by year